| General Information of Drug Metabolite (DM) (ID: DM019949) |
| DM Name |
20(OH)D2
|
| Structure |
|
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Cholesterol desmolase (CYP11A1)
|
DME0099
|
| Unclear - Unclear |
Ergocalciferol
|
[1] |
|
|
|
|
|
|
|
| DME(s) Metabolizing This DM |
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| Ergocalciferol |
DR0596
|
Approved |
Hypoparathyroidism |
|
|
| References |
| 1 |
The Metabolic Activation of Sofosbuvir Is Impaired in an Experimental Model of NAFLD. Biology (Basel). 2022 Apr 30;11(5):693. doi: 10.3390/biology11050693.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.